Evidence map›Paper›PMID 31069266›Full record

Trial reportCommunications biology2019

Yasuhiko Matsumoto, Masaki Ishii, Setsuo Hasegawa, Kazuhisa Sekimizu

Open access · goldAbstract readClinical Trial
In one paragraph

Trial report in Communications biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
4.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Enterococcus faecalis: implications for host health.World journal of microbiology & biotechnology · 2024
    Review
  5. Review
  6. Article
  7. Extraction Optimization, Preliminary Identification, and Bioactivities in Corn Silk.Evidence-based complementary and alternative medicine : eCAM · 2023
    Article
  8. Article
  9. Pharmaceutics · 2022
    Article
  10. Article
  11. Silkworm model forVirulence · 2021
    Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Yasuhiko Matsumoto1Teikyo University Institute of Medical Mycology, 359 Otsuka, Hachioji, Tokyo, 192-0395 Japan.
Masaki Ishii3Molecular Cell Biology Laboratory, Research Institute of Pharmaceutical Sciences, Faculty of Pharmacy, Musashino University, 1-1-20 Shinmachi Nishitokyo-shi, Tokyo, 202-8585 Japan.
Setsuo HasegawaPharmaspur Inc., Toyo building, 1-2-10 Nihonbashi, Chuo-ku, Tokyo, 103-0027 Japan.
Kazuhisa Sekimizu1Teikyo University Institute of Medical Mycology, 359 Otsuka, Hachioji, Tokyo, 192-0395 Japan.
Musashino University · JPTeikyo University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hyperglycemia caused by excessive intake of sucrose leads to lifestyle-related diseases such as diabetes. Administration of a lactic acid bacterial strain to mice suppresses sucrose-induced hyperglycemia, but evidence for a similar effect in humans is lacking. Here we show that

Indexed as

AnimalsBiological TransportBombyxCaco-2 CellsDisease Models, AnimalDNA Transposable ElementsEnterococcus faecalisGlucoseHemolymphHumansHyperglycemiaIntestinal MucosaMutagenesis, InsertionalSucroseSymbiosisDNA Transposable ElementsGlucoseSucroseAnimal disease modelsExperimental models of diseaseMetabolic disordersPreclinical researchTranslational research

Identifiers

PMID31069266
PMCPMC6497652
OpenAlexW2942654590

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.